Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II

Gustavo Gonzalez-Cuevas; Francisco Navarrete; Maria S Garcia-Gutierrez; Giordano de Guglielmo; Jorge Manzanares

doi:10.3389/fphar.2023.1163991

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II

Front Pharmacol. 2023 Feb 23:14:1163991. doi: 10.3389/fphar.2023.1163991. eCollection 2023.

Authors

Gustavo Gonzalez-Cuevas^{1

2}, Francisco Navarrete^{3

4

5}, Maria S Garcia-Gutierrez^{3

4

5}, Giordano de Guglielmo⁶, Jorge Manzanares^{3

4

5}

Affiliations

¹ Department of Clinical Psychopharmacology, College of Pharmacy, Idaho State University, Meridian, ID, United States.
² Department of Psychological Science, Boise State University, Boise, ID, United States.
³ Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, San Juan de Alicante, Alicante, Spain.
⁴ Redes de Investigación Cooperativa Orientada a Resultados en Salud (RICORS), Red de Investigación en Atención Primaria de Adicciones (RIAPAd), Instituto de Salud Carlos II, MICINN and FEDER, Madrid, Spain.
⁵ Instituto de Investigación, Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.
⁶ Department of Psychiatry, University of California San Diego, La Jolla, CA, United States.

No abstract available

Keywords: Alzheimer’s disease; CBD; Parkinson’s diseae; acetaminophen, mood disorders, autism spectrum disorder (ASD); cannabidiol; neurotherapeutics; psychiatric disorders.

Publication types

Editorial